Cancer-focused CRO OncoBay signs on with physIQ’s latest clinical trial partner program
Originally published in Fierce Biotech
Media Mentions
physIQ unveils new partner program for CROs, other research groups
Originally published in FierceBiotech
Think RPM is too big for your small practice? Think again.
Originally published in Medical Economics
InCarda, PhysIQ and Syneos team for phase 3 flecainide study
Originally published in Fierce Biotech
Syneos joins with physIQ, InCarda on atrial fibrillation study
Originally published in Outsourcing Pharma
physIQ, InCarda Therapeutics to collaborate on AFib treatment tech
Originally published in MassDevice
Getting ‘Personal’ With Vaccine Development
Originally published in Pharmaceutical Executive